| (Values in U.S. Thousands) | Mar, 2019 | Dec, 2018 | Sep, 2018 | Jun, 2018 | Mar, 2018 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | -1,980 | -2,570 | -160 | -4,030 | -2,690 |
| Net Income Growth | +22.96% | -1,506.26% | +96.03% | -49.81% | unch |
Contravir Pharmaceuticals (CTRV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
ContraVir Pharmaceuticals Inc. is a biopharmaceutical company. The company is involved in the discovery and development of antiviral therapies. ContraVir Pharmaceuticals Inc. is headquartered in Edison, New Jersey.